Deka Bank Deutsche Girozentrale Homology Medicines, Inc. Transaction History

Deka Bank Deutsche Girozentrale

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$3.64 - $7.78 $140,140 - $299,530	-38,500 Closed	0 $0
Q4 2020 Mar 12, 2021	BUY	$8.92 - $13.29 $223,000 - $332,250	25,000 Added 185.19%	38,500 $436,000
Q3 2020 Oct 29, 2020	BUY	$9.94 - $16.59 $134,190 - $223,965	13,500 New	13,500 $140,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.